Abstract: A strontium compound, a method of making a thin film with the strontium compound, and a method of manufacturing a semiconductor device including the thin film. The strontium compound is represented by Chemical Formula 1: In Chemical Formula 1, n, L1, L2, A, and m are as defined herein.

Abstract: An organometallic compound, represented by Formula 1: wherein, Ln1 is a ligand represented by Formula 1-1, Ln2 is a ligand represented by Formula 2-1 or 2-2, n1 is 1, 2, or 3, and n2 is 0, 1, or 2, wherein CY1 is a benzoquinoline group or a benzoisoquinoline group, X31 and X32 are each independently O or S; R10, R21 to R28, R31 to R37, R41 to R44, and b10 are as defined herein; and * and *? each indicate a binding site to M1.

Abstract: A process of forming an oxide layer, the oxide layer, a semiconductor device, and a method for manufacturing a semiconductor device. The process of forming the oxide layer including conducting atomic layer deposition at a temperature of less than about 400° C., wherein the atomic layer deposition includes: supplying a metal or semi-metal precursor and a first reaction catalyst to a substrate positioned in a chamber for atomic layer deposition to adsorb the metal or the semi-metal precursor on a surface of the substrate; and supplying a reactant and a second reaction catalyst to the substrate on which the metal or semi-metal precursor is adsorbed to form the oxide layer, wherein the first reaction catalyst and the second reaction catalyst comprise primary or secondary amine, respectively.

Abstract: Provided are an organometallic compound represented by Formula 1, an organic light-emitting device including the same, and an electronic apparatus including the organic light-emitting device: wherein, in Formula 1, Y2, ring CY1, ring CY2, T1, T2, A1 to A7, a1, and a2 are as defined in the specification.

Abstract: An organometallic compound represented by Formula 1, an organic light-emitting device including the same, and a diagnostic composition including the organometallic compound: wherein, Formula 1, R1 to R12 and R21 to R23 are each independently the same as described in the detailed description of the specification.

Abstract: An organometallic compound represented by Formula 1: wherein, in Formula 1, R37 is hydrogen, deuterium, a substituted or unsubstituted C1-C60 alkyl group, a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C2-C10 heterocycloalkyl group, a substituted or unsubstituted C6-C60 aryl group, a substituted or unsubstituted C2-C60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, or a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group; and ring CY1, R21 to R26, R30a, and R30b, are as described herein.

Abstract: An organometallic compound represented by Formula 1: wherein, in Formula 1, R37 is hydrogen, deuterium, a substituted or unsubstituted C1-C60 alkyl group, a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C2-C10 heterocycloalkyl group, a substituted or unsubstituted C6-C60 aryl group, a substituted or unsubstituted C2-C60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, or a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group; and ring CY1, R21 to R26, R30a, and R30b, are as described herein.

Abstract: Provided are an organometallic compound represented by Formula 1 and an organic light-emitting device including the same: wherein, in Formula 1, Y1, Y2, Xa, Xb, ring CY1, ring CY2, R1, R2, A1 to A7, a1, and a2 are as defined in the specification.

Abstract: An organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound: wherein, in Formula 1, R1 to R9, R21 to R23, and A1 to A7 are each independently the same as described herein.

Abstract: An organometallic compound, wherein the organometallic compound has a C2 symmetric structure, and is represented by Formula 1, wherein the sum of ?(Ir—N) and ?(Ir—C) is about 0.002 angstroms or less: Ir(L1)2(L2)??Formula 1 wherein, in Formula 1, L1 is a ligand represented by Formula 2 as provided herein, wherein one of two L1s is a first L1 ligand and the other L1s is a second L1 ligand and the first L1 ligand and the second L1 ligand are identical to each other, L2 is a ligand represented by Formula 3 as provided herein, and ?(Ir—N) and ?(Ir—C) are as defined herein.

Abstract: Provided is an organometallic compound represented by Formula 1, an organic light-emitting device including the same, and an electronic apparatus including the organic light-emitting device. Ir(L1)(L2)(L3)??Formula 1 L1 to L3 in Formula 1 are the same as described in the present specification.

Abstract: A heterocyclic compound represented by Formula 1: and an organic light-emitting device including the same are provided.

Abstract: An organometallic compound represented by Formula 1: wherein, Formula 1, R1 to R10 and A1 to A7 are the same as described in the detailed description of the specification.

Abstract: An organometallic compound represented by Formula 1 and an organic light-emitting device including the same: Y2, ring A2, R1 to R8, R13 to R20, and d2 in Formula 1 may be each independently the same as described in the specification.

Abstract: An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2??Formula 1 wherein, M1 is a transition metal, L1 is ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2: wherein X1 to X4 are each independently C or N; Y1 is O, S, Se, C(R5)(R6), N(R7), or Si(R8)(R9); ring CY2 and ring CY4 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group; ring CY3 is a 5-membered heterocyclic group, a 5-membered heterocyclic group condensed with a C5-C30 carbocyclic group, or a 5-membered heterocyclic group condensed with a C1-C30 heterocyclic group; * and *? each indicate a binding site to M1; and the remaining descriptions of Formulae 1A and 2B as described herein.

Abstract: A heterocyclic compound represented by Formula 1: and an organic light-emitting device including the same are provided.

Abstract: An organometallic compound represented by Formula 1 and an organic light-emitting device including the same: Y2, ring A2, R1 to R8, R13 to R20, and d2 in Formula 1 may be each independently the same as described in the specification.

Abstract: An organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound: wherein, in Formula 1, Y2, a ring CY2, R1 to R8, R20, A1 to A7 and d2 may be each independently the same as described in the specification.

Abstract: An organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound: wherein, in Formula 1, Y2, a ring CY2, R1 to R8, R20, A1 to A7 and d2 may be each independently the same as described in the specification.

Abstract: An organometallic compound represented by Formula 1: wherein, Y1 to Y4 are each independently C or N, one of Y1 to Y4 is N bonded to Ir in Formula 1, and one of the remaining Y1 to Y4 is C bonded to ring CY2 in Formula 1, Y9 is O, S, N(R19), C(R19a)(R19b), or Si(R19a)(R19b), X2 is C, ring CY1 and ring CY2 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group, Z1 is a group represented by —Si(Q3)(Q4)(Q5) or a group represented by —Ge(Q3)(Q4)(Q5), a1 is an integer from 0 to 2, a2 is an integer from 0 to 20, b1 and b2 are each independently an integer from 1 to 10, and R1, R19, R19a, R19b, R2, R30a, R30b, R37, and Z2 are as described herein.